Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.

Neoplasia · 2017 · PMC5565633 · PMID 28830009

Europe PMC DOI

hedged sentence

0.0506

closest p · 1.0× alpha

0.0506

boldest claim

The sentences

approached significanceP = .0506so close (0.05 < p ≤ 0.1)

At day 50, tumors were removed and while the volumes of the removed tumors remained significantly different, tumor weight only approached significance ( P = .0506) in the H2aL2a-DM1 group ( Figure 11 B ).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.